Oxford Nanopore Technologies (LON:ONT) Stock Price Down 10.2% – Time to Sell?

Oxford Nanopore Technologies plc (LON:ONT) fell 10.2% during mid-day trading on Monday . The stock traded as low as GBX 127 ($1.59) and last traded at GBX 128.50 ($1.61). 3,354,197 shares traded hands during mid-day trading, an increase of 54% from the average session volume of 2,182,529 shares. The stock had previously closed at GBX 143.10 ($1.79).

Analyst Ratings Changes

Several brokerages recently weighed in on ONT. Berenberg Bank reissued a “buy” rating and set a GBX 282 ($3.54) price target on shares of Oxford Nanopore Technologies in a research report on Tuesday, September 3rd. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 190 ($2.38) target price on shares of Oxford Nanopore Technologies in a report on Wednesday, September 4th. Finally, JPMorgan Chase & Co. reaffirmed an “overweight” rating on shares of Oxford Nanopore Technologies in a report on Friday, December 6th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of GBX 235.50 ($2.95).

Oxford Nanopore Technologies Price Performance

The company has a debt-to-equity ratio of 8.07, a quick ratio of 6.01 and a current ratio of 4.45. The firm has a fifty day simple moving average of GBX 142.50 and a two-hundred day simple moving average of GBX 129.78. The firm has a market cap of £1.21 billion, a PE ratio of -642.50 and a beta of 0.80.

Insider Transactions at Oxford Nanopore Technologies

In related news, insider Gurdial (Gordon) Sanghera sold 1,993,571 shares of the stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of GBX 142 ($1.78), for a total value of £2,830,870.82 ($3,548,791.30). Insiders have acquired a total of 310 shares of company stock worth $45,010 in the last three months. Insiders own 32.62% of the company’s stock.

Oxford Nanopore Technologies Company Profile

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.